Russell R. Lonser
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
504
Citations
15,556
Est. group size
~22
Recurring co-author estimate
Active years
38
Publishing since 1989
Russell R. Lonser's research focuses on neurosurgical techniques for delivering gene and cell therapies directly into the brain and spinal cord to treat conditions such as Parkinson's disease, Alzheimer's disease, brain tumors (gliomas, hemangioblastomas, meningiomas), and hydrocephalus. A major focus is convection-enhanced delivery (a method of infusing therapeutic agents directly into brain tissue under controlled pressure) and improving the precision of these procedures using robotic and imaging guidance. This work spans clinical trials, surgical technique development, and studies of inherited tumor syndromes like von Hippel-Lindau disease.
Publication output was fairly steady from 2017-2022 (roughly 10-19 per year) before rising sharply in 2023-2025, suggesting a recent period of growing productivity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Direct image-guided convective perfusion of the bilateral thalami for gene therapy in frontotemporal dementia: technical note
Journal of neurosurgery · 2026
- High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome
Journal of Neuro-Oncology · 2026
- Robot-Assisted Placement of Convection-Enhanced Delivery Infusion Cannulas
Operative Neurosurgery · 2026
- Hemangioblastomas of the Spinal Cord
Neurosurgery Clinics of North America · 2026
- CT-guided robotic placement of multiple convective delivery cannulas
Journal of neurosurgery · 2026
- A Phase 1 Study of Convection‐Enhanced Delivery of Intraputaminal <scp>AAV2</scp> ‐ <scp>GDNF</scp> in Advanced Parkinson's Disease
Movement Disorders · 2026
- Direct delivery of gene- and cell-based therapies to the nervous system. Image-Guided Biologic Therapies: Neurosurgeons Innovating Treatment Excellence Summit summary
Journal of neurosurgery · 2025
- A Phase I Clinical Trial of AAV2‐BDNF Gene Therapy for Alzheimer's Disease: Findings
Alzheimer s & Dementia · 2025
- Hydrocephalus and Disorders of Intracranial Pressure
Neurosurgery Clinics of North America · 2025
- 1360 Faculty and Resident Perspectives on Collective Bargaining Efforts by Resident Physicians in the United States
Neurosurgery · 2025
- Neurosurgical faculty and resident perspectives on collective bargaining efforts by resident physicians in the United States
Journal of neurosurgery · 2025
- TIP-03. ADePT A phase I/II study of an AAV-1 mediated dual-payload gene therapy in patients with high grade glioma
Neuro-Oncology · 2025
- DDDR-48. An AAV-1 mediated dual-payload gene therapy for high grade glioma
Neuro-Oncology · 2025
- Figure S3 from Proteostasis Modulation in Germline Missense von Hippel Lindau Disease
2025
- Figure S2 from Proteostasis Modulation in Germline Missense von Hippel Lindau Disease
2025
- Neurosurgery×21
- Journal of neurosurgery×18
- Neurosurgery Clinics of North America×11
- Neuro-Oncology×10
- Operative Neurosurgery×6
- Smita Kumari
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Chaylen Andolino
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Aneesha Dasgupta
Biochemistry, Genetics and Molecular Biology · Indiana University
- Anjali Gupta
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Charles E. Dann
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile